TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $180K of Entrada Therapeutics, Inc.
Sold$179,862
$17.99Price
10,000Shares
−21%Stake
What TRDA did after the filing
- The stock from Wed, Jul 12 close, $15.78
- +4.2%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Aug 23 close.
Traded Mon, Jul 10. Filed Wed, Jul 12, 12:34 PM ET, during the session. Returns use the Jul 12 close and the Aug 23 close. Not investment advice.